Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
From bumpy, scaly patches and intense itching to triggers like stress and sunburn, psoriasis can affect various parts of your body. If joint pain or family history is…
This session dives into the etiopathogenesis of rheumatoid arthritis (RA). Learn about RA’s impact on joints, its genetic and environmental triggers, and the roles of T and B…
